Stroke Treatment Reduces Depression

August 14, 2013

Neurological Wellness Center physicians respond to a recent survey finding 37% of stroke survivors develop depression and report the alleviation of depression is a predictable outcome of perispinally administered Enbrel treatment for stroke.

(PRWEB) August 14, 2013

An estimated 700,000 people have a stroke in the United States each year, and approximately 37% of stroke survivors develop depression within 2 years according to survey published in NewsFix*. Several studies have shown that stroke patients who develop depression recover more slowly and are more likely to die within ten years than stroke patients who don’t become depressed. There is now substantial and accumulating basic science and clinical evidence linking neuro-inflammation with severe depression. In a landmark study published in the Journal Neuropsychopharmacology, Susana G. Torres-Platas analyzed the brains of suicide victims and concludes: "The presence of hypertrophic astrocytes in BA24 white matter is consistent with reports suggesting white matter alterations in depression, and provides further support to the neuro-inflammatory theory of depression." ** Perispinally injected Enbrel is a means of administering a powerful long-lasting anti-inflammatory agent to the brain.

The standard treatment protocol Neurological Wellness Center physicians employ for individuals who have experienced a stroke is just one to four perispinal injections of 25 mg etanercept over up to a 40 day period coupled with oral minocycline 100 mg 2X daily for 50 days. "This treatment interrupts a self-perpetuating cycle of inflammation that can persist for years after the stroke," Rolando Hernandez M.D. neurosurgeon for Neurological Wellness Center. This dosage of Enbrel is quite low compared to the recommended dose for moderate rheumatic psoriasis. This dose of minocycline is the same as that commonly used to treat adolescent acne. "The short term perispinal Enbrel (PSE) treatment we employ can be a real lifesaver for individuals with stroke who are suffering with depression.

"Perispinal Enbrel as a TBI treatment has many attributes. (1) The therapeutic window is wide. A person who's stroke occurred a decade ago or even longer may still benefit. (2) The treatment is short term, involving just one to four injections over a period of up to forty days, yet the benefits are long lasting. (3) The dosage of Enbrel needed to achieve these results is quite low compared to the FDA recommendations for moderate plaque psoriasis. The FDA protocol for moderate plaque psoriasis calls for 24 injections, totaling 1200 mg of Enbrel over a three month period, followed by weekly injections for life. (4) The recovery can begin to occur in minutes and can build with subsequent injections over the course of treatment," stated Dr. Hernandez.

In order for injections of Enbrel to be effective, they must be administered to the soft fatty tissue in the back of the neck between cervical vertebrae C-5 and C-6. This simple subcutaneous injection, performed with a fine gauge ½ inch needle, is referred to as a perispinal injection. Neurological Wellness Center offers a complete two-hour course on Alzheimer's treatment, stroke treatment and traumatic brain injury treatment covering all aspects of perispinal injection technique at their Neurological Wellness Center in Managua, Nicaragua.

For many, flying to the Neurological Wellness Center in Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at http://www.neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua, Nicaragua, authorized this press release.

The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. Enbrel is a highly advertised, commonly prescribed drug manufactured by Immunex for Amgen / Pfizer. Over 400,000 Americans self inject Enbrel each week, mostly as a treatment for rheumatoid arthritis. Enbrel is a powerful anti-inflammatory agent. Dr. Augusto believes many of the impairments people with stroke experience are due to a self-perpetuating cascade of inflammation that was initiated by the brain injury. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. “Fortunately for the millions of people now afflicted with Alzheimer’s, stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel,” said Dr. Rolando Hernandez M.D.

To enroll in a hands-on instructional course on perispinal injections, visit http://www.reversealzheimersnow.com.

To purchase an instructional video and e-book on administering perispinal injections, visit http://www.neurological-recovery-guide.com.


**nature.com/npp/journal/v36/n13/abs/npp2011154a.html Astrocytic Hypertrophy in Anterior Cingulate White Matter of Depressed Suicides 2011

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb10949307.htm

Source: prweb

comments powered by Disqus